SG3 Management, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$1,005,888
+51.7%
24,800
+148.0%
0.14%
+1015.4%
Q4 2021$663,000
-85.8%
10,000
-86.6%
0.01%
-90.8%
Q3 2021$4,673,000
+1611.7%
74,849
+2168.2%
0.14%
+1320.0%
Q2 2021$273,000
-97.2%
3,300
-97.7%
0.01%
-95.9%
Q1 2021$9,668,000
+1160.5%
145,800
+1358.0%
0.24%
+1513.3%
Q4 2020$767,000
+78.0%
10,0000.0%0.02%
-6.2%
Q3 2020$431,000
+1624.0%
10,000
+400.0%
0.02%
+166.7%
Q4 2018$25,0002,0000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders